SAN DIEGO, April 15, 2026 /PRNewswire/ -- Alida Biosciences today announced the launch of its EpiPlex™ Tri-Mod™ Service, enabling simultaneous detection and quantification of three key mRNA ...

A more effective vaccine technology may be on the horizon. In a new study in mice, researchers from the University of Copenhagen demonstrate that a simple addition to mRNA vaccines can significantly ...

RNA modifications have emerged as a pivotal area of focus in molecular biology and precision medicine. Recent breakthroughs highlight the dynamic nature of ...

Advanced analytics and artificial intelligence (AI) will help make mRNA vaccines and therapeutics better by allowing biopharma engineers to fine-tune the enzymes used to manufacture such products.

N4-Acetylation of cytidine (ac4C) is an mRNA modification that enhances cellular mRNA stability and translation. Most eukaryotic organisms catalyze ac4C using a homologue of human N-acetyltransferase ...

CD BioGlyco launched its Therapeutic Nucleic Acid Development Platform. The company says the platform combines nucleic acid synthesis and delivery into a single service. Most platforms only handle one ...

The MarketWatch News Department was not involved in the creation of this content. SAN DIEGO, April 15, 2026 /PRNewswire/ -- Alida Biosciences today announced the launch of its EpiPlex(TM) Tri-Mod(TM) ...